John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$254M |
| 2 |
Bank of America
BAC
|
+$228M |
| 3 |
KLA
KLAC
|
+$205M |
| 4 |
TSMC
TSM
|
+$191M |
| 5 |
CVS Health
CVS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Meta Platforms (Facebook)
META
|
+$254M |
| 3 |
Goldman Sachs
GS
|
+$237M |
| 4 |
Amazon
AMZN
|
+$229M |
| 5 |
PayPal
PYPL
|
+$212M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.63% |
| 2 | Healthcare | 13.66% |
| 3 | Financials | 12.92% |
| 4 | Industrials | 10.81% |
| 5 | Consumer Discretionary | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Texas Pacific Land
TPL
$25.8B
| $1.15M | ﹤0.01% |
3,900
-2,388
| -38% | -$656K |
|
2002
Silicon Laboratories
SLAB
$7.28B
| $1.15M | ﹤0.01% |
9,944
-8,371
| -46% | -$934K |
|
2003
4D Molecular Therapeutics
FDMT
$850M
| $1.15M | ﹤0.01% |
105,972
+78,449
| +285% | +$1.3M |
|
2004
Atea Pharmaceuticals
AVIR
$442M
| $1.14M | ﹤0.01% |
341,761
-33,314
| -9% | -$121K |
|
2005
Resources Connection
RGP
$147M
| $1.14M | ﹤0.01% |
117,772
+32,562
| +38% | +$336K |
|
2006
Alerus Financial
ALRS
$818M
| $1.14M | ﹤0.01% |
49,828
-12,985
| -21% | -$277K |
|
2007
Nurix Therapeutics
NRIX
$2.73B
| $1.14M | ﹤0.01% |
50,709
-10,179
| -17% | -$231K |
|
|
AOMR
2008
Angel Oak Mortgage REIT
AOMR
$196M
| $1.14M | ﹤0.01% |
109,107
+77,857
| +249% | +$899K |
|
2009
SPX Corp
SPXC
$10.1B
| $1.14M | ﹤0.01% |
7,132
-39,312
| -85% | -$5.93M |
|
2010
VEON
VEON
$4.21B
| $1.13M | ﹤0.01% |
37,199
+17,157
| +86% | +$472K |
|
2011
Third Coast Bancshares
TCBX
$760M
| $1.13M | ﹤0.01% |
42,231
+14,971
| +55% | +$358K |
|
|
JNPR
2012
DELISTED
Juniper Networks
JNPR
| $1.13M | ﹤0.01% |
28,884
+571
| +2% | +$21.8K |
|
2013
Capital City Bank Group
CCBG
$883M
| $1.12M | ﹤0.01% |
31,787
+7,091
| +29% | +$233K |
|
|
ALEX
2014
DELISTED
Alexander & Baldwin
ALEX
| $1.12M | ﹤0.01% |
58,386
-18,449
| -24% | -$348K |
|
|
TBRG
2015
DELISTED
TruBridge
TBRG
| $1.12M | ﹤0.01% |
93,624
-45,465
| -33% | -$529K |
|
|
TRML
2016
DELISTED
Tourmaline Bio
TRML
| $1.11M | ﹤0.01% |
43,345
-119,889
| -73% | -$2M |
|
2017
Universal Technical Institute
UTI
$1.21B
| $1.11M | ﹤0.01% |
68,449
-15,459
| -18% | -$265K |
|
2018
State Street SPDR S&P Transportation ETF
XTN
$371M
| $1.11M | ﹤0.01% |
+13,500
| New | +$1.06M |
|
2019
Woori Financial
WF
$16.9B
| $1.11M | ﹤0.01% |
+31,060
| New | +$1.07M |
|
2020
First Trust Health Care AlphaDEX Fund
FXH
$1.17B
| $1.11M | ﹤0.01% |
9,900
+7,200
| +267% | +$789K |
|
2021
First Financial Bancorp
FFBC
$3.46B
| $1.11M | ﹤0.01% |
43,821
-22,438
| -34% | -$563K |
|
2022
UroGen Pharma
URGN
$2.26B
| $1.11M | ﹤0.01% |
87,034
-13,388
| -13% | -$199K |
|
2023
Willdan Group
WLDN
$1.27B
| $1.1M | ﹤0.01% |
26,963
+939
| +4% | +$33.7K |
|
2024
Gilat Satellite Networks
GILT
$766M
| $1.1M | ﹤0.01% |
209,154
+156,294
| +296% | +$718K |
|
|
ECO
2025
Okeanis Eco Tankers
ECO
$2.54B
| $1.1M | ﹤0.01% |
33,747
+5,443
| +19% | +$170K |
|
Similar funds
John Overdeck's Q3 2024 Portfolio in Review
As of Q3 2024, John Overdeck held 3,433 positions worth $45.6B, up 3.9% from $43.9B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.
John Overdeck withdrew a net $1.83B in Q3 2024, closing 348 positions and reducing 1,306 holdings. Its most notable exit was Intel, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, John Overdeck opened a new position in Bank of America worth $226M.
- John Overdeck's largest Q3 2024 buy was Bank of America: 5,683,991 shares worth $226M.
- John Overdeck added most to Alphabet (Google) Class A in Q3 2024, an estimated $254M increase.
- John Overdeck's biggest Q3 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.06B.
- John Overdeck fully exited Intel in Q3 2024, selling an estimated $161M.
- John Overdeck's ten largest holdings make up 6.6% of its $45.6B portfolio in Q3 2024.
- John Overdeck opened 444 new positions and closed 348 in Q3 2024.
- John Overdeck's portfolio value rose 3.9% quarter-over-quarter to $45.6B.
Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.